Feds ban stun guns! Here's the shocking market impact...
A Ground Floor Opportunity for Investing in Modern Weapons Technology
From Geoffery Eiten, publisher of
OTC Growth Stock Watch newsletter
A Registered Investment Advisor.
He is one of the most respected and often referenced newsletter publishers by
financial news sources like Barron's, Fortune, Investment Reporter and others.
The company he recommends you buy today is:
Lamperd Less Lethal, Inc.
OTCBB Ticker: LLLI
Privately Founded: 1994
Now Publicly Traded Since: March, 2005 (Reverse merger 3/18/05)
Current Share Price: $0.77
Target price: $4.62
Projection: 600% growth/24 months
Recommendation: Aggressive Buy Now
Here's the story:
If you've been following the shocking rise and fall of the stun gun industry,
then you'll recognize how...
HOMELAND SECURITY CREATED THIS ELECTRIFYING OPPORTUNITY FOR INDIVIDUAL
INVESTORS...
THEY BANNED ALL STUN GUNS...
INCLUDING TASERS!
Two years ago, Taser (TASR) made investors rich in a stunning one-year, 5,611%
growth bonanza!
Investors made profits as high as $55,110 for every $1,000 invested!
Now, on the heels of the stun gun ban, the non-lethal weapons market is set to
soar again, only this time, you won't make your money with TASR.
In 2003, stun gun sales triggered a 5,611% profit explosion for TASR investors.
Now it appears the stun gun market is on the verge of collapse and a new leader
is set to emerge!
And here's the part that could make you a fortune. Despite Taser's woes, the
market for non-lethal weapons appears to be better than ever!
* Police departments are building new non-lethal arsenals.
* Security agencies are expanding non-lethal capabilities.
* Even the military is beginning a non-lethal arms build-up.
This is not just happening in America, this is happening worldwide!
And here's the company that could take the lion's share of the market...just
like Taser did in 2003!
Lamperd Less Lethal, Inc. (OTCBB: LLLI) has staked a commanding position in
global non-lethal weapons manufacturing. And if history repeats itself, you
could see profit-making action that will blow you away!
-
Dear Profit Minded Investor...
In 2003-2004, the non-lethal weapons market skyrocketed, scoring TASR investors
an incredible 56-fold investment gain in just one year. Had you been on board
then...
You'd have seen your $10,000 start return pure profits of up to $551,100 in only
12 months!
Did you miss it?
Don't worry...you're about to get a second chance!
Today, the enormous market for non-lethal weapons is set to take off all over
again. I'll explain more about that in a moment, but first, let me tell you
about the amazing company I've uncovered as a "must buy" for subscribers to my
OTC Growth Stock Watch newsletter.
After reading my report, I hope you'll agree that this could be the profit
making-buy of a lifetime.
Though I'm only "officially" saying that Lamperd Less Lethal (LLLI) stockholders
could see 600% growth in 24 months, my less conservative side says that LLLI
stock in 2005 could repeat the TASR story and yield results like the mind-
blowing 5,611% growth figure that made TASR investors millions.
You do not want to be on the sidelines as this story unfolds!
Here's why I am telling my readers to consider investing in LLLI right now.
Earlier this year, in an unpublicized reverse merger, Lamperd Less Lethal became
publicly traded. It was an essential step in the company's aggressive (and
achievable) growth plans.
As a privately held company, Lamperd Less Lethal built an 11-year history of
non-lethal weapons sales...with a current catalog of around 250 products.
Though very few outside law enforcement know about Lamperd Less Lethal, the
company and its products are well known and widely used throughout the United
States, Canada, Great Britain and now, parts of the Middle East. What's more,
Lamperd is one of the very few small companies worldwide approved for sales to
NATO.
Though their past performance has certainly been impressive, the growth
potential for Lamperd could just be getting started. With the apparent demise of
the stun gun and with USA Today's recent report (March 17, 2005) that Homeland
Security has banned stun guns, the non-lethal market is set to take off all over
again.
In fact, the market potential for non-lethal weapons over the next few years is
so big...
Lamperd Less Lethal projects its sales will hit a whopping $28 million by the
end of 2006!
That's over $3.5 million more revenue than Taser saw at its sales peak...
Can you understand why I see this as an enormous profit making opportunity?
Not only are major new markets for non-lethal weapons emerging worldwide, the
stun gun leader, Taser International, is in major decline.
It's no wonder. Stun guns are reported to be killing people, failing in use, and
triggering an avalanche of lawsuits. The situation has become dire. TASR
investors are getting hammered. Over the last few months, their share prices
have fallen about 2/3rds off the former high.
But don't think for a minute that the market for non-lethal weapons is drying
up.
Non-lethal weapons are in high demand...because virtually every police
department I've researched reports a major need for an effective non-lethal
sidearm. And with the experiences they've had to date, my bet is that it won't
be for another generation of deadly stun guns.
That's where the new Lamperd Defender I sidearm is making its mark.
In the field, the stun gun just doesn't live up to modern weapons standards. It
fires just one shot before reloading, has a maximum range of only 7 to 12 yards,
is miserably inaccurate, and fails to work as intended in as many as 1 out of 4
deployments. Not very impressive, especially when your life is on the line!
By comparison, Lamperd's law enforcement sidearm, the Defender 1, has far
greater accuracy and dependability.
* It fires up to five rounds of non-lethal projectiles per load,
* Has an effective range of up to 70 feet,
* Is dependable and accurate at all ranges,
* Can chamber other non-lethal and tactical munitions, plus...
Lamperd's patented butyl composite WASP(tm) blunt force projectile strikes with
a force that cannot be ignored!
A few years ago, Lamperd Less Lethal and the University of Western Ontario
jointly patented the butyl composite material for use in Lamperd's blunt force
projectile as a more effective alternative to commonly used (and deadly) rubber
bullets.
Unlike rubber bullets which freeze and harden to metallic stiffness, Lamperd's
WASP round retains its soft properties to temperatures as low as -60? F...which
makes it useful anywhere in the world.
Lamperd Less Lethal is the only manufacturer on the planet offering anything
like it.
And that's caught the military's attention too!
Now it appears that Lamperd's WASP round is heading toward "must have" status in
more places than the stun gun makers ever dreamed of going.
You see, not only have police and security officials taken notice (and in the
U.S. alone $7-8 billion is spent annually for police equipment)...so too has the
military.
As reported by Lamperd officials, the U.S. military has already ordered 10,000
rounds of WASP munitions. These 20-gauge rounds can deployed for use with many
conventional weapons as well as Lamperd's MPK military launcher. This weapon
provides ground troops with an effective non-lethal weapon for use in civilian-
populated war zones like Iraq and Afghanistan.
In the coming year, Lamperd Less Lethal has the real potential to become the #1
maker of non-lethal weapons in the world! And from my research, nobody even
comes close to matching what Lamperd has ready to go, right now.
This market could be taking off right now and there appears to be only one
company in the starting gate!
Hundreds of millions of dollars will be up for grabs in the coming years and
hardly anyone has noticed. Except, of course, Lamperd Less Lethal.
Over a year ago, Lamperd's management saw the opportunity and set their plans in
motion. They also recognized that going public was the only way they could gear
up for the enormous growth they saw on the horizon.
That decision to become publicly traded has created a ground floor opportunity
for investors to make what could become millions in profit dollars!
Over the last few months, Lamperd Less Lethal has tooled up to begin large-scale
production of its Defender 1, the military MPK, and most importantly, the WASP
round. The quantities being targeted make Lamperd's $28 million sales projection
a real possibility.
That's why I believe Lamperd Less Lethal, now trading OTC as LLLI, could become
one of, if not the most profitable investment you make in a lifetime.
Conservatively, I'm projecting LLLI investors who get in today will see 600%
growth in 24 months.
That means $10,000 invested now could soon grow to $60,000!
But you should also remember that in 2003...
Investors saw the market for Taser stun guns trigger 56-fold profits in just 12
months.
And it didn't stop there!
By Spring of 2004, those same investors saw share prices climb to an all-time
high of $33.45, an eye-popping 9,291% growth from the original $0.36! Had you
bought TASR back then...
$10,000 held through the all-time high grew to a staggering $929,100!
Do you really want to miss profit potential like this in 2005?
If you are an aggressive investor, I already know the answer. That's why I urge
you to consider LLLI for your portfolio today.
And if you want to discover more stocks like LLLI for your portfolio, I also
urge you to consider a subscription to OTC Growth Stock Watch.
Over the years, the stock picks I've published for OTC Growth Stock Watch
subscribers have, on average, grown 320% from the date of my recommendation to
each stock's subsequent high!
320% growth on average!
I can't think of any newsletter that has even come close to that record.
You can learn more about subscribing to OTC Growth Stock Watch through the link
below. But first, I recommend you make your decision about Lamperd Less Lethal
(OTCBB: LLLI) today.
Just remember, should this stock take off like I think it will, you heard about
it first from me!
Yours for profitable investing,
-
Geoffery Eiten
Publisher, OTC Growth Stock Watch
P.S. I'm no stranger to finding stocks with quadruple-digit (1,000% or better)
growth.
Over the years, my subscribers have been alerted to growth buys like this:
7,050% on Express Scripts (ESRX)First recommended: 9/92 @ $1.19 - 3/15/05 $84.91 current
4,217% on Natural MicroSystems (NMSS)First recommended: 4/94 @ $1.56 - with subsequent high 9/7/00 of $84.91
3,089% on Advance PCS (ADVP)First recommended: 12/96 @ $1.19 - sell recommended 9/15/03 $36.76
1,111% to 1,909% on Techne Corporation (TECH)First recommended: 6/93 @ $3.43 - 3/15/05 $41.54 current with subsequent high of
$71.06 on 7/6/00
1,085% on Surmodics (SRDX)First recommended: 5/98 @ $4.88 - with subsequent high 6/28/01 of $66.90
Of course, not all of these stocks gain at the same time, nor do all of them do
this well.
But keep in mind my 320% average growth record mentioned above.
And keep in mind that Lamperd Less Lethal (OTCBB: LLLI) holds promise for
blowing way beyond figures like these. You simply DO NOT want to be on the
sidelines if that happens again!
Consider adding LLLI to your portfolio today and after you do, use the web
address below to learn more about the money-saving, stake-free subscription offer
to OTC Growth Stock Watch.
For more information about subscribing to OTC Growth Stock Watch, visit:
http://sdm3.rm04.net/ctt?kn=4&m=411471&r=MTc1MTQ0MjAzMAS2&b=2&j=ODAzNzkzMAS2&mt=1
This Special Situations Report has been sent to you by:
Geoffery Eiten
OTC Growth Stock Watch
300 Chestnut St., Ste. 200, Needham MA
02492
SUBSCRIBE IMMEDIATELY by calling: 888-268-2479
posted by Victor Lloyd Smith @ 9:33 AM
0 Comments:
Post a Comment
<< Home